Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endarterectomy, Carotid | 4 | 2024 | 556 | 1.750 |
Why?
|
Carotid Stenosis | 6 | 2024 | 859 | 1.590 |
Why?
|
Endovascular Procedures | 16 | 2024 | 2216 | 1.450 |
Why?
|
Blood Vessel Prosthesis Implantation | 11 | 2024 | 1456 | 1.190 |
Why?
|
Stents | 8 | 2024 | 3195 | 1.040 |
Why?
|
Aortic Aneurysm, Abdominal | 8 | 2024 | 1250 | 1.020 |
Why?
|
Peripheral Arterial Disease | 6 | 2024 | 1304 | 0.970 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2020 | 707 | 0.820 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.820 |
Why?
|
Ribs | 1 | 2024 | 259 | 0.820 |
Why?
|
Carotid Artery, Internal | 1 | 2024 | 440 | 0.750 |
Why?
|
Arthritis, Experimental | 2 | 2014 | 293 | 0.670 |
Why?
|
Decompression, Surgical | 1 | 2024 | 603 | 0.640 |
Why?
|
Femoral Artery | 3 | 2024 | 829 | 0.640 |
Why?
|
Spinal Cord Ischemia | 1 | 2020 | 94 | 0.630 |
Why?
|
Liver Circulation | 1 | 2018 | 159 | 0.580 |
Why?
|
Mesenteric Artery, Superior | 1 | 2018 | 96 | 0.580 |
Why?
|
Splanchnic Circulation | 1 | 2018 | 122 | 0.570 |
Why?
|
Hepatic Artery | 1 | 2018 | 232 | 0.540 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2016 | 99 | 0.520 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2024 | 2763 | 0.480 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.470 |
Why?
|
Radiography, Interventional | 2 | 2018 | 1131 | 0.430 |
Why?
|
Denervation | 1 | 2014 | 265 | 0.430 |
Why?
|
Blood Vessel Prosthesis | 3 | 2024 | 956 | 0.430 |
Why?
|
Unnecessary Procedures | 1 | 2016 | 412 | 0.410 |
Why?
|
Postoperative Hemorrhage | 1 | 2016 | 419 | 0.410 |
Why?
|
Blood Loss, Surgical | 1 | 2016 | 642 | 0.400 |
Why?
|
Hindlimb | 1 | 2014 | 516 | 0.390 |
Why?
|
Occupational Health | 1 | 2017 | 812 | 0.370 |
Why?
|
Ischemia | 5 | 2024 | 1900 | 0.350 |
Why?
|
Aortic Rupture | 3 | 2024 | 322 | 0.350 |
Why?
|
Microvessels | 1 | 2014 | 585 | 0.340 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 879 | 0.340 |
Why?
|
Saphenous Vein | 2 | 2024 | 519 | 0.330 |
Why?
|
Blood Transfusion | 1 | 2016 | 1309 | 0.330 |
Why?
|
Bacteriocins | 1 | 2009 | 85 | 0.320 |
Why?
|
Radiation Dosage | 1 | 2017 | 1967 | 0.320 |
Why?
|
Treatment Outcome | 22 | 2024 | 65371 | 0.300 |
Why?
|
Androstenes | 1 | 2009 | 177 | 0.300 |
Why?
|
Occupational Exposure | 1 | 2017 | 1807 | 0.280 |
Why?
|
Prodrugs | 1 | 2009 | 274 | 0.280 |
Why?
|
Bone Substitutes | 3 | 2006 | 233 | 0.280 |
Why?
|
Limb Salvage | 3 | 2024 | 488 | 0.270 |
Why?
|
Time Factors | 17 | 2024 | 40218 | 0.260 |
Why?
|
Osteoblasts | 3 | 2006 | 1145 | 0.250 |
Why?
|
Risk Factors | 18 | 2024 | 74944 | 0.240 |
Why?
|
Lower Extremity | 3 | 2024 | 1216 | 0.240 |
Why?
|
Subclavian Vein | 1 | 2024 | 57 | 0.240 |
Why?
|
Vascular Patency | 2 | 2024 | 917 | 0.230 |
Why?
|
Health Care Costs | 1 | 2016 | 3239 | 0.210 |
Why?
|
Popliteal Artery | 1 | 2024 | 313 | 0.200 |
Why?
|
Retrospective Studies | 17 | 2024 | 81762 | 0.200 |
Why?
|
Aged | 18 | 2024 | 171504 | 0.190 |
Why?
|
Music Therapy | 2 | 2013 | 111 | 0.180 |
Why?
|
Registries | 4 | 2024 | 8375 | 0.180 |
Why?
|
Risk Assessment | 12 | 2024 | 24315 | 0.180 |
Why?
|
Wound Healing | 4 | 2024 | 2809 | 0.170 |
Why?
|
Prosthesis Design | 2 | 2024 | 2125 | 0.170 |
Why?
|
Aged, 80 and over | 12 | 2024 | 59629 | 0.160 |
Why?
|
Neutrophils | 2 | 2009 | 3786 | 0.160 |
Why?
|
Osteotomy | 1 | 2024 | 838 | 0.160 |
Why?
|
Travel | 1 | 2024 | 805 | 0.150 |
Why?
|
Vascular Grafting | 1 | 2020 | 163 | 0.150 |
Why?
|
Bone and Bones | 2 | 2006 | 2589 | 0.150 |
Why?
|
Angioplasty | 1 | 2020 | 355 | 0.150 |
Why?
|
Postoperative Complications | 6 | 2024 | 15832 | 0.140 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4427 | 0.140 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2257 | 0.140 |
Why?
|
Radiation Monitoring | 1 | 2017 | 106 | 0.140 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 2080 | 0.140 |
Why?
|
Fluoroscopy | 2 | 2018 | 947 | 0.140 |
Why?
|
Inflammation | 2 | 2014 | 10873 | 0.140 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4206 | 0.130 |
Why?
|
Thromboembolism | 1 | 2022 | 1004 | 0.130 |
Why?
|
Aspirin | 3 | 2022 | 3135 | 0.130 |
Why?
|
Male | 20 | 2024 | 364719 | 0.130 |
Why?
|
Databases, Factual | 6 | 2024 | 8080 | 0.130 |
Why?
|
Sarcoma | 3 | 2013 | 1806 | 0.120 |
Why?
|
Thrombolytic Therapy | 1 | 2024 | 2055 | 0.120 |
Why?
|
Humans | 34 | 2024 | 768166 | 0.120 |
Why?
|
Imaging, Three-Dimensional | 3 | 2018 | 4063 | 0.110 |
Why?
|
Stroke | 4 | 2024 | 9755 | 0.110 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 459 | 0.110 |
Why?
|
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2013 | 7 | 0.110 |
Why?
|
Angioplasty, Balloon | 1 | 2018 | 592 | 0.110 |
Why?
|
Minoxidil | 1 | 2013 | 35 | 0.110 |
Why?
|
Metals | 1 | 2018 | 713 | 0.110 |
Why?
|
Reoperation | 1 | 2024 | 4329 | 0.110 |
Why?
|
Gene Expression | 2 | 2005 | 7598 | 0.110 |
Why?
|
Serum | 1 | 2014 | 206 | 0.110 |
Why?
|
Paralysis | 1 | 2014 | 250 | 0.100 |
Why?
|
United States | 9 | 2024 | 73039 | 0.100 |
Why?
|
Friends | 1 | 2013 | 149 | 0.100 |
Why?
|
Workload | 1 | 2017 | 849 | 0.100 |
Why?
|
Middle Aged | 13 | 2024 | 223492 | 0.090 |
Why?
|
Rats, Inbred WKY | 3 | 2006 | 150 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3479 | 0.090 |
Why?
|
Female | 19 | 2024 | 397192 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1232 | 0.090 |
Why?
|
Ankle | 1 | 2014 | 353 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 904 | 0.090 |
Why?
|
Cell Hypoxia | 1 | 2013 | 662 | 0.090 |
Why?
|
Spinal Cord | 1 | 2018 | 1811 | 0.090 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2012 | 319 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1003 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 393 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1162 | 0.080 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2009 | 54 | 0.080 |
Why?
|
Equipment Design | 1 | 2017 | 3522 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2005 | 11669 | 0.080 |
Why?
|
Task Performance and Analysis | 1 | 2012 | 771 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 4580 | 0.070 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1402 | 0.070 |
Why?
|
Factor XIII | 1 | 2008 | 59 | 0.070 |
Why?
|
Carotid Arteries | 2 | 2022 | 942 | 0.070 |
Why?
|
Androstadienes | 1 | 2009 | 348 | 0.070 |
Why?
|
Cell Membrane Permeability | 1 | 2009 | 571 | 0.070 |
Why?
|
Spectroscopy, Near-Infrared | 2 | 2012 | 752 | 0.070 |
Why?
|
Anticoagulants | 2 | 2022 | 4852 | 0.070 |
Why?
|
Eye Neoplasms | 1 | 2009 | 306 | 0.070 |
Why?
|
Collagen | 2 | 2013 | 2643 | 0.070 |
Why?
|
Neoplasm Metastasis | 3 | 2013 | 4912 | 0.070 |
Why?
|
Tissue Engineering | 3 | 2006 | 1893 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5889 | 0.060 |
Why?
|
Heart Injuries | 1 | 2007 | 207 | 0.060 |
Why?
|
Molecular Imaging | 1 | 2012 | 826 | 0.060 |
Why?
|
Peroxidase | 1 | 2008 | 610 | 0.060 |
Why?
|
Alkaline Phosphatase | 2 | 2005 | 863 | 0.060 |
Why?
|
Vascular Surgical Procedures | 2 | 2024 | 1506 | 0.060 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2005 | 86 | 0.060 |
Why?
|
Mice | 11 | 2014 | 82029 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4260 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9669 | 0.060 |
Why?
|
Calcium Phosphates | 1 | 2005 | 173 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6809 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15454 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5536 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1124 | 0.050 |
Why?
|
Cattle | 2 | 2006 | 3819 | 0.050 |
Why?
|
Mice, Inbred BALB C | 2 | 2009 | 6231 | 0.050 |
Why?
|
Cell Adhesion | 1 | 2009 | 3096 | 0.050 |
Why?
|
Carotid Artery, Common | 1 | 2023 | 174 | 0.050 |
Why?
|
Sulfonamides | 1 | 2012 | 1982 | 0.050 |
Why?
|
Animals | 14 | 2014 | 169246 | 0.050 |
Why?
|
Peritoneal Neoplasms | 1 | 2009 | 714 | 0.050 |
Why?
|
Family | 1 | 2013 | 3209 | 0.050 |
Why?
|
Contrast Media | 1 | 2015 | 5330 | 0.050 |
Why?
|
Pyrazoles | 1 | 2012 | 2028 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2024 | 11519 | 0.050 |
Why?
|
Protamines | 1 | 2021 | 112 | 0.050 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1836 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18349 | 0.050 |
Why?
|
Stress, Psychological | 2 | 2013 | 4530 | 0.040 |
Why?
|
Laparoscopy | 1 | 2012 | 2041 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2005 | 1741 | 0.040 |
Why?
|
Ventricular Remodeling | 1 | 2008 | 1281 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2014 | 22379 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13053 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2009 | 2056 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 300 | 0.040 |
Why?
|
Length of Stay | 2 | 2024 | 6498 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2024 | 5349 | 0.040 |
Why?
|
Monocytes | 1 | 2007 | 2605 | 0.040 |
Why?
|
Anxiety | 1 | 2013 | 4672 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 60066 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2661 | 0.040 |
Why?
|
Quality Improvement | 1 | 2012 | 3857 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 89169 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2013 | 9561 | 0.030 |
Why?
|
Rats | 3 | 2006 | 23760 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2130 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2009 | 14488 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 957 | 0.030 |
Why?
|
Sarcoma, Experimental | 1 | 2013 | 117 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2013 | 7951 | 0.030 |
Why?
|
Models, Cardiovascular | 1 | 2018 | 981 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2012 | 6974 | 0.030 |
Why?
|
HT29 Cells | 1 | 2012 | 188 | 0.030 |
Why?
|
Adult | 3 | 2024 | 223646 | 0.020 |
Why?
|
Propensity Score | 1 | 2020 | 1969 | 0.020 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 4916 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8509 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3109 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5446 | 0.020 |
Why?
|
Melanoma | 1 | 2009 | 5706 | 0.020 |
Why?
|
Hemorrhage | 1 | 2022 | 3467 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10632 | 0.020 |
Why?
|
Mice, Nude | 2 | 2009 | 3623 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2005 | 4978 | 0.020 |
Why?
|
Sound | 1 | 2012 | 261 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2012 | 598 | 0.020 |
Why?
|
Insulin | 1 | 2024 | 6607 | 0.020 |
Why?
|
Fluorescent Dyes | 2 | 2009 | 1930 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9384 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7243 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 183 | 0.020 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2008 | 48 | 0.020 |
Why?
|
Dalteparin | 1 | 2008 | 44 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2566 | 0.020 |
Why?
|
Genes, p53 | 1 | 2009 | 714 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2009 | 719 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2009 | 753 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5520 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 547 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13676 | 0.020 |
Why?
|
Myogenin | 1 | 2005 | 54 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 610 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2012 | 2107 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6124 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2515 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.020 |
Why?
|
Species Specificity | 1 | 2009 | 2415 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 9538 | 0.020 |
Why?
|
Random Allocation | 1 | 2009 | 2396 | 0.010 |
Why?
|
Osseointegration | 1 | 2006 | 277 | 0.010 |
Why?
|
Stress, Physiological | 1 | 2012 | 1408 | 0.010 |
Why?
|
Receptors, Cholinergic | 1 | 2005 | 244 | 0.010 |
Why?
|
Myoblasts | 1 | 2005 | 234 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2006 | 475 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2012 | 3611 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3800 | 0.010 |
Why?
|
Fibrin | 1 | 2005 | 514 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 1140 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 1989 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2830 | 0.010 |
Why?
|
Injections | 1 | 2005 | 840 | 0.010 |
Why?
|
Genome | 1 | 2009 | 1754 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5210 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 2828 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 1429 | 0.010 |
Why?
|
Soft Tissue Neoplasms | 1 | 2009 | 1164 | 0.010 |
Why?
|
Education, Medical | 1 | 2012 | 1742 | 0.010 |
Why?
|
Kinetics | 1 | 2007 | 6329 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 54926 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2420 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2005 | 19015 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2013 | 12465 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 2937 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2006 | 1702 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8542 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5902 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2720 | 0.010 |
Why?
|
Genotype | 1 | 2009 | 13045 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2008 | 3941 | 0.010 |
Why?
|
Stroke Volume | 1 | 2008 | 5622 | 0.010 |
Why?
|
Genomics | 1 | 2009 | 5926 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 17140 | 0.010 |
Why?
|
Models, Statistical | 1 | 2006 | 5107 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 14164 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11928 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 36743 | 0.000 |
Why?
|